primary open angle glaucoma (POAG)

Aerpio Pharmaceuticals encouraged phase 1b trial of topical ocular formulation for primary open angle glaucoma

Aerpio Pharmaceutical encouraged by the early safety findings and potential efficacy signal of this ongoing Phase 1b trial.

FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer June 2, 2020
CytoSMART Technologies announces the launch of the CytoSMART Lux2 Duo Kit June 2, 2020
Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline June 2, 2020
Toronto centre solving cell manufacturing challenges to benefit patients and global industry June 2, 2020
Global Oligonucleotide Synthesis, Modification and Purification Services Market – Manufacturers Offering Oligonucleotide Chemistries and Components for Delivery of COVID-19 Detection Kits At Scale June 2, 2020
520,144 Orion Corporation A shares converted into B shares June 2, 2020
Vistin Pharma ASA: Mandatory notification of trade June 2, 2020